first "biologic therapy" for allergy-related asthma, called Xolair (ZO-lair)

The FDA just approved the first "biologic therapy" for allergy-related asthma, called Xolair (ZO-lair).

Xolair (omalizumab) is an important new option...but only for a select group of asthma patients.

It's only for patients with moderate to severe asthma triggered by an allergic reaction...only when inhaled steroids aren't enough...and only in patients 12 and older.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote